产品介绍
Product Description
|
规格 |
|
| Accession Number: | NM_004720 |
| Assay Entry: | Cell-based beta-arrestin recruitment |
| Cell Line: | U2OS |
| Cell State: | Dividing Cells |
| Cytoplasmic Tail: | Tail from AVPR2 GPCR |
| Druggable Target: | GPCRs |
| Gene Symbol: | EDG4 |
| Population Status: | Pool of Stable Cells |
| Product Line: | Tango™ |
| Reporter Gene: | BLA (Beta-Lactamase) |
| System Type: | Tango™ |
| Target Entry: | EDG4 |
| Detection Method: | Fluorescent |
|
储存 |
|
|
(LiveBLAzer™-FRET B/G Loading Kit, Solution D and other materials are required separately; please refer to the protocol). Includes: o Tango™ EDG4-bla U2OS cells o Tango™ EDG4-bla U2OS Assay Protocol o Certificate of Analysis The Tango™ EDG4-bla U2OS cells are shipped on dry ice and should be stored in liquid nitrogen immediately upon receipt. |
|
描述 |
The Tango™ EDG4-bla U2OS cells contain the human Endothelial Differentiation Gene 4 (EDG4) linked to a TEV protease site and a Gal4-VP16 transcription factor stably integrated into the Tango™ GPCR-bla U2OS parental cell line. This parental cell line stably expresses a beta-arrestin/TEV protease fusion protein and the beta-lactamase (bla) reporter gene under the control of a UAS response element.
The Tango™ EDG4-bla U2OS DA cells have been functionally validated for Z' factor and EC50 concentrations of LPA (18:1). In addition, Tango™ EDG4-bla U2OS cells have been tested for assay performance under variable conditions. These data are found in the Validation & Assay Performance Summary in the Manuals and Brochures section.
